Clinical trial
Open-label Pilot Study of Abatacept for the Treatment of Vitiligo
NCT02281058 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-label Pilot Study of Abatacept for the Treatment of Vitiligo
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- January 31, 2015
- Completion date
- May 31, 2018
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.